Toward a better understanding of European Lyme neuroborreliosis

Clinical Infectious Diseases

Volumn 57, Issue 4, 2013, Pages 510-512

  Wormser, Gary P ^a   Halperin, John J ^b,c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Overlook Medical Center   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Erythema migrans; Lyme borreliosis; Lyme disease; Meningitis; Neuroborreliosis

Indexed keywords

CEFTRIAXONE; DOXYCYCLINE;

ANTIBIOTIC THERAPY; ARTHRITIS; BLOOD CULTURE; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; BORRELIA INFECTION; CEREBROSPINAL FLUID CULTURE; DIZZINESS; ERYTHEMA CHRONICUM MIGRANS; EUROPE; EVIDENCE BASED PRACTICE; FACIAL NERVE PARALYSIS; HEADACHE; HUMAN; INOCULATION; LUMBAR PUNCTURE; LYME DISEASE; MENINGITIS; MONONEUROPATHY MULTIPLEX; MYOCARDITIS; NAUSEA; NECK PAIN; NEUROTROPISM; NOTE; PARESTHESIA; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADICULAR PAIN; RADICULOPATHY; SEROLOGY; SKIN DEFECT; SPECIES; TICK BORNE ENCEPHALITIS FLAVIVIRUS; TREATMENT RESPONSE; TREPONEMA PALLIDUM; VIRULENCE; VOMITING;

ERYTHEMA MIGRANS; LYME BORRELIOSIS; LYME DISEASE; MENINGITIS; NEUROBORRELIOSIS;

BORRELIA; FEMALE; GLOSSITIS, BENIGN MIGRATORY; HUMANS; LYME NEUROBORRELIOSIS; MALE;

EID: 84880942340     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit322     Document Type: Note

References (23)

1. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet 2012; 379:461-73.
2. van Dam AP, Kuiper H, Vos K, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993; 17:708-17.
3. Strle F, Ruzic-Sabljic E, Cimperman J, Lotric-Furlan S, Maraspin V. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 2006; 43:704-10.
4. Ekerfelt C, Ernerudh J, Forsberg P, Bergstrom S. Augmented intrathecal secretion of interferon-gamma in response to Borrelia garinii in neuroborreliosis. J Neuroimmunol 1998; 89:177-81.
5. Brisson D, Baxamusa N, Schwartz I, Wormser GP. Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One 2011; 6:e22926.
6. Seinost G, Dykhuizen DE, Dattwyler RJ, et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 1999; 67:3518-24.
7. Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 1998; 26:151-64.
8. Cadavid D, Sondey M, Garcia E, Lawson CL. Residual brain infection in relapsing-fever borreliosis. J Infect Dis 2006; 193:1451-8.
9. Ogrinc K, Lotric-Furlan S, Maraspin V, Cerar T, Ruzic-Sabljic E, Strle F. Suspected early Lyme neuroborreliosis in patients with erythema migrans [published online ahead of print 10 May 2013]. Clin Infect Dis 2013; 57:501-9.
10. Nadelman RB, Nowakowski J, Forseter G, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 1996; 100:502-8.
11. Logar M, Ruzic-Sabljic E, Maraspin V, et al. Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii. Infection 2004; 32:15-9.
12. Rupprecht TA, Kirschning CJ, Popp B, et al. Borrelia garinii induces CXCL13 production in human monocytes through toll-like receptor 2. Infect Immun 2007; 75:4351-6.
13. Alitalo A, Meri T, Comstedt P, et al. Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis. Eur J Immunol 2005; 35:3043-53.
14. Marconi RT, Hohenberger S, Jauris-Heipke S, et al. Genetic analysis of Borrelia garinii OspA serotype 4 strains associated with neuroborreliosis: evidence for extensive genetic homogeneity. J Clin Microbiol 1999; 37:3965-70.
15. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992; 115(Pt 2):399-423.
16. Stiernstedt G, Gustafsson R, Karlsson M, Svenungsson B, Skoldenberg B. Clinical manifestations and diagnosis of neuroborreliosis. Ann NY Acad Med 1988; 539:46-55.
17. Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C. Yield of large-volume blood cultures in patients with early Lyme disease. J Infect Dis 2001; 184:1070-2.
18. Cerar T, Ogrinc K, Cimperman J, Lotric-Furlan S, Strle F, Ruzić-Sabljić E. Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 2008; 46:3375-9.
19. Avery RA, Frank G, Eppes SC. Diagnostic utility of Borrelia burgdorferi cerebrospinal fluid polymerase chain reaction in children with Lyme meningitis. Pediatr Infect Dis J 2005; 24:705-8.
20. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008; 70:992-1003.
21. Lukehart SA, Hook EW III, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HN. Invasion of central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988; 109:855-62.
22. Ljøstad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 2008; 7: 690-5.
23. Wormser GP, Halperin JJ. Oral doxycycline for neuroborreliosis. Lancet Neurol 2008; 7: 665-6.